Indivior (INDV)

Sector:

Pharma and Biotech

Index:

FTSE 250

1,383.00p
   
  • Change Today:
      10.00p
  • 52 Week High: 1,998.00
  • 52 Week Low: 1,360.00
  • Currency: UK Pounds
  • Shares Issued: 136.32m
  • Volume: 435,561
  • Market Cap: £1,885.24m
  • RiskGrade: 314

Latest ShareCast News

Indivior shares tumble as group sets aside $290m for US litigation

By Iain Gilbert

Date: Thursday 16 Feb 2023

(Sharecast News) - Shares in pharmaceuticals business Indivior tumbled early on Thursday after the group revealed it had put aside $290.0m for ongoing litigation in the States.

Indivior raises guidance for peak net revenue potential of Sublocade asset

By Iain Gilbert

Date: Wednesday 07 Dec 2022

(Sharecast News) - Pharmaceuticals business Indivior upgraded guidance for the peak annual net revenue potential of its Sublocade asset on Wednesday ahead of its Capital Markets Day event in New York City.

Indivior to buy US overdose treatment firm Opiant for $145m

By Frank Prenesti

Date: Monday 14 Nov 2022

(Sharecast News) - UK-based drug company Indivior said it would pay $145m for Opiant Pharmaceuticals which produces treatments to overcome opioid addiction.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Indivior Market Data

Currency UK Pounds
Share Price 1,383.00p
Change Today 10.00p
% Change 0.73 %
52 Week High 1,998.00
52 Week Low 1,360.00
Volume 435,561
Shares Issued 136.32m
Market Cap £1,885.24m
RiskGrade 314

Indivior Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
53.56% below the market average53.56% below the market average53.56% below the market average53.56% below the market average53.56% below the market average
72.88% below the sector average72.88% below the sector average72.88% below the sector average72.88% below the sector average72.88% below the sector average
Price Trend
53.13% above the market average53.13% above the market average53.13% above the market average53.13% above the market average53.13% above the market average
68.25% above the sector average68.25% above the sector average68.25% above the sector average68.25% above the sector average68.25% above the sector average
Income Not Available
Growth
26.60% above the market average26.60% above the market average26.60% above the market average26.60% above the market average26.60% above the market average
47.62% above the sector average47.62% above the sector average47.62% above the sector average47.62% above the sector average47.62% above the sector average

What The Brokers Say

Strong Buy 2
Buy 2
Neutral 0
Sell 0
Strong Sell 0
Total 4
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Indivior Dividends

No dividends found

Trades for 30-Mar-2023

Time Volume / Share Price
16:38 6,721 @ 1,383.00p
16:38 2,657 @ 1,383.00p
16:38 721 @ 1,383.00p
16:35 196,717 @ 1,383.00p
16:35 42 @ 1,383.00p

Indivior Key Personnel

CEO Mark Crossley
Chair Graham Hetherington

Top of Page